Janusz Myśliwiec, Łukasz Zukowski, Anna Grodzka, Agata Piłaszewicz, Szymon Dragowski, Maria Górska
{"title":"原发性醛固酮增多症的诊断:是否有必要进行确证性检查?","authors":"Janusz Myśliwiec, Łukasz Zukowski, Anna Grodzka, Agata Piłaszewicz, Szymon Dragowski, Maria Górska","doi":"10.1177/1470320312438791","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Assessment of the renin-angiotensin-aldosterone system has been recently granted a much greater role in the evaluation of patients with arterial hypertension. There is no single test efficient in selection of patients for second-step etiological investigation.</p><p><strong>Methods: </strong>Altogether, 198 consecutive patients--119 women (60%) and 79 men (40%)--hospitalized in years 2009-2011 at the Clinical Department of Endocrinology Medical University of Bialystok were diagnosed with primary aldosteronism. In each patient, plasma renin activity and plasma aldosterone concentration (basic and after 2 l NaCl infusion) were evaluated.</p><p><strong>Results: </strong>The percentage of patients with plasma aldosterone concentration ≥ 15 ng/ml was 53 and the percentage of patients with plasma renin activity ≤ 0.1 ng/ml/h was 20. The percentage of patients screened for primary aldosteronism in which the aldosterone:renin ratio exceeded consecutive cut-offs of 20, 30, 40 and 50 were respectively 57, 45, 34 and 29. Among 15 patients in which plasma aldosterone concentration after infusion of 2 l of saline was ≥ 6.5 ng/dl (8.6%), 13 (6.6%) were diagnosed with primary aldosteronism.</p><p><strong>Conclusion: </strong>The obligatory use of tests confirming autonomy of aldosterone secretion in patients screened for primary aldosteronism seems cost-effective in limiting the number of patients for further diagnosis.</p>","PeriodicalId":520698,"journal":{"name":"Journal of the renin-angiotensin-aldosterone system : JRAAS","volume":" ","pages":"367-71"},"PeriodicalIF":0.0000,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1470320312438791","citationCount":"11","resultStr":"{\"title\":\"Diagnostics of primary aldosteronism: is obligatory use of confirmatory tests justified?\",\"authors\":\"Janusz Myśliwiec, Łukasz Zukowski, Anna Grodzka, Agata Piłaszewicz, Szymon Dragowski, Maria Górska\",\"doi\":\"10.1177/1470320312438791\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Assessment of the renin-angiotensin-aldosterone system has been recently granted a much greater role in the evaluation of patients with arterial hypertension. There is no single test efficient in selection of patients for second-step etiological investigation.</p><p><strong>Methods: </strong>Altogether, 198 consecutive patients--119 women (60%) and 79 men (40%)--hospitalized in years 2009-2011 at the Clinical Department of Endocrinology Medical University of Bialystok were diagnosed with primary aldosteronism. In each patient, plasma renin activity and plasma aldosterone concentration (basic and after 2 l NaCl infusion) were evaluated.</p><p><strong>Results: </strong>The percentage of patients with plasma aldosterone concentration ≥ 15 ng/ml was 53 and the percentage of patients with plasma renin activity ≤ 0.1 ng/ml/h was 20. The percentage of patients screened for primary aldosteronism in which the aldosterone:renin ratio exceeded consecutive cut-offs of 20, 30, 40 and 50 were respectively 57, 45, 34 and 29. Among 15 patients in which plasma aldosterone concentration after infusion of 2 l of saline was ≥ 6.5 ng/dl (8.6%), 13 (6.6%) were diagnosed with primary aldosteronism.</p><p><strong>Conclusion: </strong>The obligatory use of tests confirming autonomy of aldosterone secretion in patients screened for primary aldosteronism seems cost-effective in limiting the number of patients for further diagnosis.</p>\",\"PeriodicalId\":520698,\"journal\":{\"name\":\"Journal of the renin-angiotensin-aldosterone system : JRAAS\",\"volume\":\" \",\"pages\":\"367-71\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/1470320312438791\",\"citationCount\":\"11\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the renin-angiotensin-aldosterone system : JRAAS\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/1470320312438791\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2012/3/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the renin-angiotensin-aldosterone system : JRAAS","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/1470320312438791","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/3/8 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11
摘要
导论:肾素-血管紧张素-醛固酮系统的评估最近在动脉性高血压患者的评估中被赋予了更大的作用。没有单一的测试有效地选择患者进行第二步病因调查。方法:2009-2011年在比亚韦斯托克医科大学内分泌临床科诊断为原发性醛固酮增多症的198例连续患者,其中119例女性(60%)和79例男性(40%)。在每位患者中,评估血浆肾素活性和血浆醛固酮浓度(基础和2 l NaCl输注后)。结果:血浆醛固酮浓度≥15 ng/ml的患者占53例,血浆肾素活性≤0.1 ng/ml/h的患者占20例。原发性醛固酮增多症筛查中醛固酮:肾素比值连续超过20、30、40和50临界值的患者比例分别为57、45、34和29。15例患者输注2l生理盐水后血浆醛固酮浓度≥6.5 ng/dl(8.6%),其中13例(6.6%)诊断为原发性醛固酮增多症。结论:在筛查原发性醛固酮增多症的患者中,强制性使用醛固酮自主分泌测试,在限制进一步诊断的患者数量方面似乎具有成本效益。
Diagnostics of primary aldosteronism: is obligatory use of confirmatory tests justified?
Introduction: Assessment of the renin-angiotensin-aldosterone system has been recently granted a much greater role in the evaluation of patients with arterial hypertension. There is no single test efficient in selection of patients for second-step etiological investigation.
Methods: Altogether, 198 consecutive patients--119 women (60%) and 79 men (40%)--hospitalized in years 2009-2011 at the Clinical Department of Endocrinology Medical University of Bialystok were diagnosed with primary aldosteronism. In each patient, plasma renin activity and plasma aldosterone concentration (basic and after 2 l NaCl infusion) were evaluated.
Results: The percentage of patients with plasma aldosterone concentration ≥ 15 ng/ml was 53 and the percentage of patients with plasma renin activity ≤ 0.1 ng/ml/h was 20. The percentage of patients screened for primary aldosteronism in which the aldosterone:renin ratio exceeded consecutive cut-offs of 20, 30, 40 and 50 were respectively 57, 45, 34 and 29. Among 15 patients in which plasma aldosterone concentration after infusion of 2 l of saline was ≥ 6.5 ng/dl (8.6%), 13 (6.6%) were diagnosed with primary aldosteronism.
Conclusion: The obligatory use of tests confirming autonomy of aldosterone secretion in patients screened for primary aldosteronism seems cost-effective in limiting the number of patients for further diagnosis.